Image

Navigating Advanced Illness Goals And Treatment With Digital Engagement (NAVIGATE)

Navigating Advanced Illness Goals And Treatment With Digital Engagement (NAVIGATE)

Recruiting
21 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this two-armed, parallel-design, pre-/post-intervention assessment clinical trial is to learn if a digital and interactive website helps to improve advance care planning (ACP) engagement among caregivers of patients with serious illness. The main questions it aims to answer are:

Does the website increase ACP engagement of caregivers of patients with serious illness? Researchers will compare the digital and interactive website to the usual care (a digital booklet) to see if the digital intervention works to improve ACP engagement among caregivers.

Participants who are caregivers will:

  • Be introduced to a digital website and asked to explore the site over the course of the study.
  • Complete four self-administered questionnaires (baseline, one-week, six-week, and six-month).

Participants who are patients will not have any intervention assigned and will only have their observational data collected through four interviewer-administered questionnaires (baseline, one-week, six-week, and six-month)

Eligibility

  1. Patient Participants Inclusion Criteria:
    1. Singapore resident aged 21years and above,
    2. patient able to identify one main caregiver in the care and medical decision-making for the patient;
    3. patient able to communicate in either English, Chinese, Malay or Tamil;
    4. patient meeting one of the following illness criteria: 4a. Patients with brain tumours: histological and/or radiological diagnosis of glioma or brain metastases.

4b. Patients with spontaneous intracerebral haemorrhage (SICH) based on radiological diagnosis of SICH on baseline computed-tomographic scans.

4c. Patients with CKD Stage 4 and 5, identified at G4 or G5 of CKD, glomerular filtration rate (GFR) 30 ml/min or less, inclusive of kidney failure on kidney replacement therapy; and (5) Physicians assessment that ACP is appropriate for the patient by physicians. () The attending clinicians may base the assessment of ACP appropriateness on several factors in addition to high mortality risk. As a baseline, clinicians are asked to base their assessment of high mortality risk using the validated "Surprise" question.

2. Patient participants Exclusion Criteria:

  1. Patients unable to identify a caregiver who is a medical decision-maker,
  2. Patients are currently or was previously healthcare workers; or
  3. Patients are diagnosed with dementia or deemed cognitively impaired as determined by the Abbreviated Mental Test.
  4. Caregiver Participants Inclusion Criteria:
  5. caregivers are identified as a medical decision-maker for the patient
  6. Singapore resident aged 21 years and above; and
  7. able to communicate in English
  8. Caregiver Participants Exclusion Criteria:
  9. caregivers are currently or were previously healthcare workers;
  10. caregivers not involved in primary care of the patient (including providing care to the patient, supervision of care, or involved in making decisions regarding treatment the patient receives); or
  11. caregivers diagnosed with dementia.

Study details
    Paliative Care
    Advance Care Planning
    Digital Education Interventions
    Values
    Social
    Goals of Care

NCT07134881

National University of Singapore

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.